The sensitivity of human tissues to changes in dose fractionation: deductions from the RCR survey among UK radiotherapists.
dc.contributor.author | Hendry, Jolyon H | |
dc.contributor.author | Roberts, Stephen A | |
dc.date.accessioned | 2010-06-10T08:48:26Z | |
dc.date.available | 2010-06-10T08:48:26Z | |
dc.date.issued | 1991-01 | |
dc.identifier.citation | The sensitivity of human tissues to changes in dose fractionation: deductions from the RCR survey among UK radiotherapists. 1991, 3 (1):22-7 Clin Oncol (R Coll Radiol) | en |
dc.identifier.issn | 0936-6555 | |
dc.identifier.pmid | 2001338 | |
dc.identifier.doi | 10.1016/S0936-6555(05)81151-3 | |
dc.identifier.uri | http://hdl.handle.net/10541/104597 | |
dc.description.abstract | The dosage prescriptions reported in the Royal College of Radiologists' fractionation survey among radiotherapists have been further analysed using model equations in order to deduce estimates of fractionation-sensitivity parameters for each of the six cases under consideration. For example, using the linear-quadratic model, including a (significant) time factor, with radical treatments of a T2 breast carcinoma or a T1N0 squamous carcinoma of the vocal cord, the (alpha/beta) ratios were 26 +/- 20 Gy and 37 +/- 46 Gy, respectively. The values of the time factor, expressed as the maximum extra dose required per day to counteract the decrease in effect with increasing overall time (gamma/alpha), were 0.60 and 0.45 Gy/day respectively. Using the Ellis formula, which provided a significantly better fit to the dosage prescription (P = 0.003), the exponents of N were calculated to be 0.24 +/- 0.05 and 0.27 +/- 0.07, respectively. The corresponding values of the T exponent were 0.16 +/- 0.06 and 0.014 +/- 0.075. About 20% of radiotherapists prescribed doses greater than +/- 10% from the mean fitted values for the breast treatment, and about 6% of them in the case of the vocal cord. | |
dc.language.iso | en | en |
dc.subject | Breast Cancer | en |
dc.subject | Bronchial Cancer | en |
dc.subject | Cancer | en |
dc.subject | Rectal Cancer | en |
dc.subject.mesh | Aged | |
dc.subject.mesh | Breast Neoplasms | |
dc.subject.mesh | Bronchial Neoplasms | |
dc.subject.mesh | Carcinoma, Squamous Cell | |
dc.subject.mesh | Data Interpretation, Statistical | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Neoplasms | |
dc.subject.mesh | Radiation Tolerance | |
dc.subject.mesh | Radiotherapy Dosage | |
dc.subject.mesh | Rectal Neoplasms | |
dc.title | The sensitivity of human tissues to changes in dose fractionation: deductions from the RCR survey among UK radiotherapists. | en |
dc.type | Article | en |
dc.contributor.department | Cancer Research Campaign Department, Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester, UK. | en |
dc.identifier.journal | Clinical Oncology | en |
html.description.abstract | The dosage prescriptions reported in the Royal College of Radiologists' fractionation survey among radiotherapists have been further analysed using model equations in order to deduce estimates of fractionation-sensitivity parameters for each of the six cases under consideration. For example, using the linear-quadratic model, including a (significant) time factor, with radical treatments of a T2 breast carcinoma or a T1N0 squamous carcinoma of the vocal cord, the (alpha/beta) ratios were 26 +/- 20 Gy and 37 +/- 46 Gy, respectively. The values of the time factor, expressed as the maximum extra dose required per day to counteract the decrease in effect with increasing overall time (gamma/alpha), were 0.60 and 0.45 Gy/day respectively. Using the Ellis formula, which provided a significantly better fit to the dosage prescription (P = 0.003), the exponents of N were calculated to be 0.24 +/- 0.05 and 0.27 +/- 0.07, respectively. The corresponding values of the T exponent were 0.16 +/- 0.06 and 0.014 +/- 0.075. About 20% of radiotherapists prescribed doses greater than +/- 10% from the mean fitted values for the breast treatment, and about 6% of them in the case of the vocal cord. |